Indian pharma major Sun Pharmaceutical Industries announced this morning that it had received approval from the US health regulator, USFDA to launch the generic version of Eli Lilly's schizophrenia treatment drug, Zyprexa in the US market, PTI reported.
According to the report, the approval by the United States Food and Drug Administration is for the abbreviated new drug application (ANDA) of olanzapine tablets in multiple dosages of 2.5 mg, 5 mg, 7.5 mg, 10 mg and 20 mg, Sun Pharma said in a statement.
According to the company, olanzapine tablets have annual sale of about $ 3.3 billion in the US. What is more, these tablets are indicated for treatment of schizophrenia, bipolar I disorder which are associated with manic or mixed episodes.
